Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2009-01-14 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE HAVRE (76600), Seine-Maritime
PHARMACIE DU ROND POINT : revenue, balance sheet and financial ratios
PHARMACIE DU ROND POINT is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE HAVRE (76600),
this company of category PME
shows in 2023 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU ROND POINT (SIREN 509892402)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 917 399 €
N/C
N/C
N/C
2 120 458 €
N/C
N/C
1 827 151 €
Net income
224 914 €
194 290 €
239 249 €
245 420 €
223 752 €
220 981 €
183 900 €
171 203 €
169 674 €
161 416 €
EBITDA
N/C
N/C
348 140 €
N/C
N/C
N/C
270 191 €
N/C
N/C
253 307 €
Net margin
N/C
N/C
8.2%
N/C
N/C
N/C
8.7%
N/C
N/C
8.8%
Revenue and income statement
In 2025, PHARMACIE DU ROND POINT generates positive net income of 225 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 161 k€ -> 225 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
224 914 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 19%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
18.768%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
75.09%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU ROND POINT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
220.764
145.183
104.351
97.839
72.042
52.545
38.264
34.198
25.444
18.768
Financial autonomy
27.024
35.918
42.527
45.217
51.734
58.982
64.299
65.038
70.816
75.09
Repayment capacity
5.575
None
None
4.161
None
None
None
1.982
None
None
Cash flow / Revenue
9.002%
None%
None%
9.218%
None%
None%
None%
9.099%
None%
None%
Sector positioning
Debt ratio
18.772025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE DU ROND POINT (18.77) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
75.09%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+6 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU ROND POINT (75.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
1.98 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of PHARMACIE DU ROND POINT (1.98) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 327.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
327.741
Liquidity indicators evolution PHARMACIE DU ROND POINT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
90.162
120.449
140.485
167.899
202.472
227.848
264.745
264.136
296.272
327.741
Interest coverage
8.695
None
None
3.275
None
None
None
1.863
None
None
Sector positioning
Liquidity ratio
327.742025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of PHARMACIE DU ROND POINT (327.74) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.86x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DU ROND POINT (1.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU ROND POINT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
184 561 €
0 €
0 €
258 081 €
0 €
0 €
0 €
404 381 €
0 €
0 €
Inventory turnover (days)
30
0
0
31
0
0
0
26
0
0
Customer payment term (days)
6
0
0
8
0
0
0
6
0
0
Supplier payment term (days)
41
0
0
33
0
0
0
37
0
0
Positioning of PHARMACIE DU ROND POINT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU ROND POINT is estimated at
3 572 785 €
(range 2 424 509€ - 5 606 192€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2424k€3572k€5606k€
3 572 785 €Range: 2 424 509€ - 5 606 192€
NAF 5 année 2025
Valuation method used
Net Income Multiple
224 914 €
×
15.9x
=3 572 786 €
Range: 2 424 509€ - 5 606 193€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU ROND POINT with other companies in the same sector:
Frequently asked questions about PHARMACIE DU ROND POINT
What is the revenue of PHARMACIE DU ROND POINT ?
The revenue of PHARMACIE DU ROND POINT in 2023 is 2.9 M€.
Is PHARMACIE DU ROND POINT profitable?
Yes, PHARMACIE DU ROND POINT generated a net profit of 225 k€ in 2025.
Where is the headquarters of PHARMACIE DU ROND POINT ?
The headquarters of PHARMACIE DU ROND POINT is located in LE HAVRE (76600), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE DU ROND POINT ?
The tax return of PHARMACIE DU ROND POINT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU ROND POINT operate?
PHARMACIE DU ROND POINT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart